79266586 - INVENTAGE

Information

  • Trademark
  • 79266586
  • Serial Number
    79266586
  • Registration Number
    6071903
  • Filing Date
    July 05, 2019
    5 years ago
  • Registration Date
    June 09, 2020
    4 years ago
  • Transaction Date
    October 25, 2020
    4 years ago
  • Status Date
    June 09, 2020
    4 years ago
  • Published for Opposition Date
    March 24, 2020
    4 years ago
  • Location Date
    June 09, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KLEINMAN, CORINNE ANNE
  • Attorney Docket Number
    I2420.82499U
    Attorney Name
    Paul G. Johnson
    Law Office Assigned Location Code
    N40
  • Owners
Mark Drawing Code
4000
Mark Identification
INVENTAGE
Case File Statements
  • GS0051: Medicinal infusions for treating dementia, diabetes, obesity, andropathy, alopecia, incurable disease, chronic disease, lipolysis, and boosting the immune system; Medicinal infusions for treating dirofilaria immitis diseases, infectious diseases, skeletal and muscular disorders, cardiovascular and circulatory diseases, nervous system diseases, ocular disorders, respiratory diseases, gastrointestinal diseases, endocrine diseases, kidney diseases, hormonal diseases, and oncological diseases and disorders of animals; implantable medicines in the nature of surgical implants comprised of living tissues; pharmaceutical compositions for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical compositions for animal skincare; pharmaceutical compositions for skin care; pharmaceutical compositions for treating dirofilaria immitis diseases, infectious diseases, skeletal and muscular disorders, cardiovascular and circulatory diseases, nervous system diseases, ocular disorders, respiratory diseases, gastrointestinal diseases, endocrine diseases, kidney diseases, hormonal diseases, and oncological diseases and disorders of animals; medicines for human purposes, namely, medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; drugs in the nature of pharmaceutical preparations for medical purposes, namely, for the treatment of oncological, gastrointestinal, metabolic, chronic, endocrine, respiratory, neurological and ophthalmic diseases and disorders; therapeutic drugs and agents in the nature of therapeutic pharmaceutical and agents for the treatment of oncological, gastrointestinal, metabolic, chronic, endocrine, respiratory, neurological and ophthalmic diseases and disorders; therapeutic drugs and agents in the nature of therapeutic pharmaceutical and agents for treating dirofilaria immitis diseases, infectious diseases, skeletal and muscular disorders, cardiovascular and circulatory diseases, nervous system diseases, ocular disorders, respiratory diseases, gastrointestinal diseases, endocrine diseases, kidney diseases, hormonal diseases, and oncological diseases and disorders of animals; chemical preparations for pharmaceutical purposes, namely, for the treatment of oncological, gastrointestinal, metabolic, chronic, endocrine, respiratory, neurological and ophthalmic diseases and disorders
  • GS0101: Medical apparatus and instruments for use in endovascular, cardiovascular, and endoscopy procedures; medical instruments for use in drug delivery systems; medical instruments for use in monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events; medical instruments for use in treating osteoarthritis, osteoporosis, osteotraumatic injuries, degenerative bone diseases and joint diseases; medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters; medical instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical filler apparatus in the nature of synthetic filler and extender material to serve as replacement for bone; medical apparatus and instruments, namely, infusion and injection devices for administering pharmaceuticals; diagnostic apparatus and instruments for medical purposes, namely, medical diagnostic apparatus for testing blood sugar levels, cancer cells, DNA, urinary protein, and cholesterol level; injection device for pharmaceuticals; medical apparatus, namely, infusion and injection devices for administering pharmaceuticals
Case File Event Statements
  • 10/25/2020 - 4 years ago
    21 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 10/2/2020 - 4 years ago
    20 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 10/2/2020 - 4 years ago
    19 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 9/9/2020 - 4 years ago
    18 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/9/2020 - 4 years ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/24/2020 - 4 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/24/2020 - 4 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/4/2020 - 4 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/14/2020 - 5 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/24/2020 - 5 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/23/2020 - 5 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/23/2020 - 5 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/19/2019 - 5 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/1/2019 - 5 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/1/2019 - 5 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/25/2019 - 5 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/24/2019 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/23/2019 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/17/2019 - 5 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/12/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 9/5/2019 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR